Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDGFRB | P09619 | 18/20 | 0.62 |
| ▸ | CSF1R | P07333 | 16/20 | 0.62 |
| ▸ | KDR | P35968 | 14/20 | 0.62 |
| ▸ | FLT3 | P36888 | 7/20 | 0.53 |
| ▸ | MET | P08581 | 2/20 | 0.52 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.52 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5610715 | 0.89 | SMN1; SMN2 (0.55) | PDGFRBCSF1RKDRFLT3MET | |
| SCHEMBL2176728 | 0.87 | PDGFRB (0.62) | PDGFRBCSF1RKDRFLT3MET | |
| SCHEMBL5598961 | 0.86 | PDGFRB (0.54) | PDGFRBCSF1RKDRFLT3MET | |
| SCHEMBL2173476 | 0.85 | PDGFRB (0.67) | PDGFRBCSF1RKDRFLT3MET | |
| SCHEMBL2172313 | 0.85 | PDGFRB (0.57) | PDGFRBCSF1RKDRFLT3MET | |
| SCHEMBL5598445 | 0.83 | PDGFRB (0.55) | PDGFRBCSF1RKDRFLT3MET | |
| SCHEMBL5598693 | 0.80 | PDGFRB (0.81) | PDGFRBCSF1RKDRFLT3MET | |
| SCHEMBL5598778 | 0.80 | PDGFRB (0.53) | PDGFRBCSF1RKDRFLT3MET | |
| SCHEMBL2176128 | 0.79 | MET (0.64) | PDGFRBCSF1RKDRFLT3MET | |
| SCHEMBL5598949 | 0.76 | PDGFRB (0.70) | PDGFRBCSF1RKDRFLT3MET |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007113565-A1 | NAPHTHYRIDINE DERIVATIVES AS ANTI-CANCER AGENTS | ASTRAZENECA AB (SE) | 2007-10-11 | — | — | WO | disclosed |